Time for Evaluation of Early Intervention and Prevention in Major Psychiatric Disorders
I n this issue, Dr Anne Duffy's paper (p 340) illustrates a renewed interest in the potential for early intervention and prevention in the major psychiatric disorders (1) . Her article reviews the basic definitions ofrisk and demonstrates the potential for integrating research advances in phenomenology, genetics, epidemiology, psychopharmacology, and the economics of health care. This integrated approach, combined with a critical review of the current state of our knowledge, supports and provides a focus for the development of strategies for early intervention and prevention.
There are 2 complementary approaches to conceptualizing disease prevention. The first indicates the timing of the intervention and the second, the target population to which intervention applies. Primary prevention strategies are implemented before onset. Secondary prevention takes place after onset, when optimal treatment may prevent the development ofchronic illness and handicap. Tertiary prevention emphasizes personal and environmental adaptation to residual deficits in functioning. The target population to which an intervention is applied may be universal, selective, or indicated. Dr Duffy reviews the evidence that supports the case for targeted secondary prevention in affective disorders.
Eaton has demonstrated the theoretical application of epidemiological data for modelling predictors for the prevention of disorders with slow onset (2). In his study, he used data from the Epidemiologic Catchment Area Program to show the best phenomenological state predictor for the development of an anxiety disorder in the subsequent year. In isolation, such predictors are of little clinical value, but the epidemiological studies also identify the incidence of the disorder, which is identified by the age of first onset. For anxiety disorders the onset is often in early adulthood (50% have an onset by 35 years ofage), yet problems begin approximately 10 years earlier. If one then becomes selective in the population to be screened, using stable risk factors such as family history, one has the beginnings ofa testable model oftargeted prevention.
Establishing strategies for relapse prevention is an important component of secondary prevention, and strategies for 338 relapse prevention in depression have recently received increased attention. This is in part the result of controversies over the increased costs of the newer antidepressants. To prove their cost-efficiency, the manufacturers ofthese antidepressants have tried to demonstrate that their increased tolerability leads to fewer treatment dropouts and consequent reduced relapse rates (3). Maintenance psychotherapy is also being investigated for its capacity to prevent relapse (4).
The potential ofearly psychosis treatment and prevention has also recently received a great deal of attention (5). Several empirical findings provide the basis for this interest. First is the consistent finding that the duration ofuntreated psychosis is related to treatment response (6). This finding is based on correlational studies with support from 1 randomized treatment study (7) . Second, deterioration seems to occur predominantly in the early years of schizophrenia (8, 9) . This has led Birchwood to articulate 3 key elements for primary and secondary prevention in schizophrenia: the detection of "at-risk mental states," early treatment of a first episode, and optimal treatment of the "critical period" (10) . Yung and McGorry have described the development of a strategy for prevention that applies the principles outlined by Eaton to schizophrenia (11). As trait risk factors, they included a first-degree relative with psychotic disorder or a schizo typal personality disorder. The state risk factor or "atrisk mental state" included low-grade psychopathology such as attenuated or subthreshold psychotic symptoms or brief, intermittent psychotic symptoms. These criteria are still preliminary but are being refined through prospective outcome studies.
In the area ofsecondary prevention, McGorry and others have described a catchment area program for early detection and intervention for psychosis (12) . This program combines public education to improve awareness, easy access to care, and rapid comprehensive assessment. Preliminary descriptive analysis of 2 cohorts of patients suggests that program improvements may have led to improved patient outcomes.
Duffy's article challenges us to look ahead and to plan the development and evaluation of early intervention and prevention programs. The first challenge for clinical research is to strengthen the identification of risk factors-especially genetic risk factors. Second, there is a need to develop and evaluate early intervention programs. Early psychosis treatment and prevention programs have already been established for the schizophrenia spectrum disorders. The challenge now for these established programs is to prove that the application of effective treatments during the early stages of psychosis can change the long-term outcome of these disorders. This will require both randomized controlled studies and also effectiveness studies. The former demonstrate that such strategies work with the population studied, while the latter show that the findings apply to real-world populations. Dr Duffy's review points to a target population for early intervention in affective disorders and hints that there are enough data to develop and evaluate intervention programs for this population.
Early intervention and prevention programs fit current philosophies of health care delivery. Such programs are population-based and needs-driven rather than demanddriven. They aspire to emphasize prevention and should be cost-effective. We have the research tools required to demonstrate the benefits ofearly intervention and prevention strategies-the challenge is to organize and fund the work.
